Zego vs AbbVie

Side-by-side comparison of AI visibility scores, market position, and capabilities

AbbVie leads in AI visibility (90 vs 22)

Zego

EmergingInsurance Tech

General

London UK commercial motor insurtech ($1.1B unicorn 2021, DST Global); Q4 2024 monthly profitable (90% COR) with 500K+ customers, 50 data points/sec telematics, cutting net loss £34M→£4M and 40% revenue growth 2025.

AI VisibilityBeta
Overall Score
D22
Category Rank
#835 of 1167
AI Consensus
57%
Trend
stable
Per Platform
ChatGPT
31
Perplexity
29
Gemini
29

About

Zego is a London, United Kingdom-based commercial motor insurtech — having raised over $300 million total including a $150 million Series C led by DST Global in 2021 at a $1.1 billion valuation (the UK's first insurtech unicorn) — providing flexible, telematics-powered commercial motor insurance to over 500,000 UK drivers and businesses across five countries including delivery drivers, rideshare operators, and commercial fleets. Founded in 2016, Zego earned its own insurance license in 2019 — enabling it to build and underwrite its own policies, collecting 50 data points per second per vehicle (5x more than competitors) — rather than acting purely as a broker or MGA relying on capacity from traditional insurers. Zego has issued over 17 million policies covering 200,000+ vehicles with terms ranging from one hour to one year. In Q4 2024, Zego achieved monthly profitability with a 90% combined operating ratio, cutting its net loss from £34 million to £4 million in 2024. Revenue grew 40% in early 2025. CEO Sten Saar has led the company since founding.

Full profile

AbbVie

LeaderHealthcare

General

Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.

AI VisibilityBeta
Overall Score
A90
Category Rank
#9 of 1167
AI Consensus
60%
Trend
stable
Per Platform
ChatGPT
99
Perplexity
99
Gemini
83

About

AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.

Full profile

AI Visibility Head-to-Head

22
Overall Score
90
#835
Category Rank
#9
57
AI Consensus
60
stable
Trend
stable
31
ChatGPT
99
29
Perplexity
99
29
Gemini
83
14
Claude
96
30
Grok
95

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.